By Adriano Marchese


Eli Lilly & Co. said Wednesday that the U.S. government has purchased 650,000 additional doses of its Bamlanivimab drug in the treatment of Covid-19 for $812.5 million.

The Indianapolis-based company said doses will be delivered through Jan. 31, with at least 350,000 of the additional doses to be delivered in December.

Bamlanivimab recently received emergency-use authorization for the treatment of mild-to-moderate Covid-19 in patients at risk of it progressing to severe.

The order brings the total purchase by the U.S. government to 950,000 doses, the company said.


Write to Adriano Marchese at


(END) Dow Jones Newswires

December 02, 2020 16:59 ET (21:59 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.